Community-reported Vfend side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Vfend Side Effect Episode
Have You dealt with a Vfend side effect? Share your experience
Review Vfend Safety Reports submitted to FDA
Total Vfend reports: 280.Vfend FDA safety alerts: No.
Reported deaths: 81 Reported hospitalizations: 87.
Take Vfend Side Effects Survey, Discuss Vfend with others
FDA Reported Vfend Side Effects: condition aggravated, visual disturbance, interstitial lung disease, death, hepatic function abnormal, depressed level of consciousness, aspartate aminotransferase increased, alanine aminotransferase increased, vision blurred, confusional state, photosensitivity reaction.
Vfend Usage.
If you have questions about Vfend, you can ask a Health Expert or Ask Patient Community about Vfend.
Showing 1-100 of 280 Next >
Vfend Side Effects Report #5353003-7Physician from PERU reported VFEND problem on May 30, 2007. Female patient, 63 years of age, was diagnosed with candida sepsis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: cholestasis, haemorrhagic stroke, thrombocytopenia, tremor, upper gastrointestinal haemorrhage. VFEND dosage: unknown. During the same period patient was treated with MEROPENEM. Patient recovered.
Vfend Side Effects Report #5356219-9
VFEND problem was reported by a Consumer or non-health professional from JAPAN on May 31, 2007. Male patient, 80 years of age, weighting 81.13 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, multi-organ failure. VFEND dosage: unknown. During the same period patient was treated with THEOPHYLLINE, SPIRIVA, SEREVENT. Patient died on 03/10/2007.
Vfend Side Effects Report #5360902-9
Physician from UNITED STATES reported VFEND problem on June 04, 2007. Female patient, weighting 119.9 lb, was diagnosed with bronchopulmonary aspergillosis, fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: aspergillosis, asthma, dyspnoea, heart rate irregular, pneumonia bacterial, respiratory failure. VFEND dosage: unknown. During the same period patient was treated with ACCOLATE, LOVENOX, PROTONIX, LISINOPRIL, NORVASC, PLAVIX, LEVAQUIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5360933-9
VFEND problem was reported by a Physician from JAPAN on June 06, 2007. Male patient, weighting 85.98 lb, was diagnosed with bronchopulmonary aspergillosis, aspergilloma and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: delusion, hallucination, pneumonia, restlessness. VFEND dosage: unknown. During the same period patient was treated with ASPIRIN, MARZULENE S, AMARYL, MAGNESIUM OXIDE, MUCOSOLVAN, CLARITHROMYCIN, MICAFUNGIN. Patient died on 04/25/2007.
Vfend Side Effects Report #5363987-9
Health Professional from FRANCE reported VFEND problem on June 11, 2007. Male patient, 58 years of age, was diagnosed with prostatitis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. VFEND dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, ZANTAC, TRANDATE, OMEPRAZOLE, VALGANCICLOVIR. Patient recovered.
Vfend Side Effects Report #5366591-1
VFEND problem was reported by a Physician from JAPAN on June 12, 2007. Female patient, 52 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. VFEND dosage: unknown. Patient recovered.
Vfend Side Effects Report #5366598-4
Pharmacist from BRAZIL reported VFEND problem on June 11, 2007. Female patient, 80 years of age, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: epilepsy. VFEND dosage: unknown. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5369665-4
VFEND problem was reported by a Physician from JAPAN on June 13, 2007. Female patient, 86 years of age, was diagnosed with respiratory moniliasis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, hepatic function abnormal. VFEND dosage: DAILY DOSE:400MG. Patient died on 06/01/2007.
Vfend Side Effects Report #5370930-5
Physician from ITALY reported VFEND problem on June 14, 2007. Female patient, weighting 116.8 lb, was diagnosed with mucosal inflammation and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: confusional state, dehydration, dysphagia, feeding disorder, hallucination, visual, renal failure acute. VFEND dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE, PARIET, VOLTAREN, OMEPRAZOLE, TRITTICO. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5373831-1
VFEND problem was reported by a Consumer or non-health professional from JAPAN on June 18, 2007. Male patient, 70 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. VFEND dosage: unknown. During the same period patient was treated with MICAFUNGIN. Patient died on 08/29/2006.
Vfend Side Effects Report #5373857-8
Consumer or non-health professional from JAPAN reported VFEND problem on June 20, 2007. Male patient, 63 years of age, weighting 108.0 lb, was diagnosed with bronchopulmonary aspergillosis, infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: pneumonia. VFEND dosage: unknown. During the same period patient was treated with MICAFUNGIN, DIFLUCAN, BAKTAR, POLYMYXIN B SULPHATE. Patient died on 02/14/2007.
Vfend Side Effects Report #5375541-3
VFEND problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Female patient, weighting 65.14 lb, was diagnosed with prophylaxis, aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: aspergillosis, dyspepsia, dyspnoea, gastrointestinal tube insertion, gastrooesophageal reflux disease, obliterative bronchiolitis, oxygen saturation decreased. VFEND dosage: unknown. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5375678-9
Physician from BRAZIL reported VFEND problem on June 15, 2007. Male patient, child 3 years of age, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: aspergillosis, complications of transplant surgery. VFEND dosage: unknown. During the same period patient was treated with AMBISOME. Patient died on 05/01/2007.
Vfend Side Effects Report #5049199-7
VFEND problem was reported by a Consumer or non-health professional from GERMANY on June 26, 2006. Male patient, 36 years of age, weighting 222.7 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, dysaesthesia, haemoptysis, hypersensitivity, infection, unevaluable event. VFEND dosage: 400 MG, ORAL. During the same period patient was treated with AMPHOTERICIN B, PREDNISOLONE, THEOPHYLLINE. Patient recovered.
Vfend Side Effects Report #5052962-X
Consumer or non-health professional from UNITED STATES reported VFEND problem on June 28, 2006. Female patient, 61 years of age, weighting 125.0 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: anorexia, chromatopsia, disorientation, middle insomnia, skin discolouration, weight decreased. VFEND dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ALPHA HYDROXY ACID, SPIRIVA, ADVAIR DISKUS, DYAZIDE, VASOTEC, ZOCOR. Patient recovered.
Vfend Side Effects Report #5061644-X
VFEND problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient, 75 years of age, was diagnosed with systemic mycosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, haematocrit decreased, haemoglobin decreased, prothrombin time prolonged, red blood cell count decreased. VFEND dosage: unknown. During the same period patient was treated with ZYVOX. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5062334-X
Physician from FRANCE reported VFEND problem on July 10, 2006. Male patient, 53 years of age, weighting 121.3 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: anaemia, computerised tomogram abnormal, hepatitis cholestatic, vein disorder. VFEND dosage: 400 MG (200 MG, FREQUENCY: BID), ORAL. During the same period patient was treated with FLUCONAZOLE, OMEPRAZOLE, ALPRAZOLAM, TRAMADOL, MORPHINE SULPHATE, FENTANYL, STAVUDINE. Patient died on 01/01/2006.
Vfend Side Effects Report #5062822-6
VFEND problem was reported by a Pharmacist from JAPAN on July 12, 2006. Female patient, 42 years of age, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, condition aggravated. VFEND dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, MAXIPIME, TARGOCID. Patient died on 02/11/2006.
Vfend Side Effects Report #5062830-5
Pharmacist from JAPAN reported VFEND problem on July 12, 2006. Male patient, 53 years of age, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: acute leukaemia, condition aggravated, vision blurred, visual disturbance. VFEND dosage: 300 MG, ORAL. During the same period patient was treated with AMIKACIN SULPHATE, SULFAMETHOXAZOLE. Patient died on 10/18/2005.
Vfend Side Effects Report #5062888-3
VFEND problem was reported by a Pharmacist from JAPAN on July 12, 2006. Male patient, 52 years of age, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bacterial infection, condition aggravated, myelodysplastic syndrome, photophobia. VFEND dosage: unknown. During the same period patient was treated with MAXIPIME, PREDNISOLONE, CYTARABINE, VEPESID, TAZOCIN. Patient died on 12/15/2005.
Vfend Side Effects Report #5062889-5
Pharmacist from JAPAN reported VFEND problem on July 12, 2006. Female patient, 80 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, condition aggravated, photophobia. VFEND dosage: unknown. During the same period patient was treated with FIRSTCIN, CARBENIN, SULFAMETHOXAZOLE, FAMOTIDINE, DEPAS. Patient died on 09/16/2005.
Vfend Side Effects Report #5062902-5
VFEND problem was reported by a Physician from FRANCE on July 10, 2006. Female patient, child 4 years of age, weighting 26.46 lb, was diagnosed with asthma, superinfection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bronchial disorder, cryoglobulinaemia, ecchymosis, oedema peripheral, pain in extremity, superinfection, toe amputation, vasculitis. VFEND dosage: 100 MG (50 MG, 2 IN 1 D), ORAL. During the same period patient was treated with DOMPERIDONE, SALBUTAMOL, FLUTICASONE PROPIONATE, BACTRIM PAEDIATRIC, GRANOCYTE, GAVISCON. Patient recovered.
Vfend Side Effects Report #5066881-6
Physician from FRANCE reported VFEND problem on July 13, 2006. Male patient, 53 years of age, weighting 121.3 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: anaemia, blood albumin decreased, hepatitis cholestatic. VFEND dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with FLUCONAZOLE, KALETRA, OMEPRAZOLE, XANAX, TRAMADOL, MORPHINE SULPHATE, MORPHINE SULPHATE. Patient died on 05/30/2006.
Vfend Side Effects Report #5070328-3
VFEND problem was reported by a Physician from GERMANY on July 17, 2006. Male patient, 65 years of age, was diagnosed with infection prophylaxis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: leukocytosis, multi-organ failure, urosepsis. VFEND dosage: unknown. Patient died on 07/15/2006.
Vfend Side Effects Report #5071666-0
Physician from JAPAN reported VFEND problem on July 19, 2006. Female patient, 65 years of age, was diagnosed with bronchopulmonary aspergillosis, interstitial lung disease and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood chloride decreased, blood pressure increased, blood sodium decreased, convulsion, depressed level of consciousness, electrolyte imbalance, gastric ulcer. VFEND dosage: 100 MG (50 MG, 2 IN 1D), INTRAVENOUS - SEE IMAGE. During the same period patient was treated with NEORAL, CORTICOSTEROIDS, PREDNISOLONE, FAMOTIDINE, ALENDRONATE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5071667-2
VFEND problem was reported by a Physician from JAPAN on July 19, 2006. Male patient, 75 years of age, was diagnosed with bronchopulmonary aspergillosis, cough, angina pectoris, anxiety disorder and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion, liver disorder, loss of consciousness. VFEND dosage: 400 MG (200 MG, FREQUENCY: BID), ORAL. During the same period patient was treated with MUCOSOLVAN, ISOSORBIDE MONONITRATE, ISOSORBIDE DINITRATE, RIZE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5072952-0
Physician from HONG KONG reported VFEND problem on July 20, 2006. Male patient, 41 years of age, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: diplopia, hallucination, vertigo, vision blurred. VFEND dosage: 400 MG (200 MG, EVERY 12 HOURS); INTRAVENOUS. During the same period patient was treated with INVANZ, AMIKIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5072955-6
VFEND problem was reported by a Physician from UNITED KINGDOM on July 12, 2006. Male patient, 58 years of age, weighting 183.4 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: agitation, amnesia, bedridden, chills, confusional state, feeling abnormal. VFEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE, RITUXIMAB, OMEPRAZOLE, AMITRIPTYLINE, ZOPICLONE. Patient recovered.
Vfend Side Effects Report #5073776-0
Physician from JAPAN reported VFEND problem on July 21, 2006. Male patient, 74 years of age, weighting 88.18 lb, was diagnosed with aspergillosis, infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm rupture, arrhythmia, back pain, cardiac disorder, cardio-respiratory arrest, delirium, hypoxia, hypoxic encephalopathy, malaise. VFEND dosage: 4 MG/KG (2 MG/KG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with MEROPEN, MICAFUNGIN, ITRACONAZOLE, LOXONIN, MUCOSTA. Patient was hospitalized. Patient died on 05/10/2006.
Vfend Side Effects Report #5076233-0
VFEND problem was reported by a Physician from JAPAN on July 24, 2006. Male patient, 20 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: photophobia, retinal haemorrhage. VFEND dosage: 400 MG, INTRAVENOUS. Patient recovered.
Vfend Side Effects Report #5077842-5
Pharmacist from JAPAN reported VFEND problem on July 25, 2006. Female patient, 18 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. VFEND dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient recovered.
Vfend Side Effects Report #5079854-4
VFEND problem was reported by a Physician from UNITED STATES on July 27, 2006. Male patient, 32 years of age, was diagnosed with fungal endocarditis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bicarbonate decreased, hypoventilation, lactic acidosis, tachypnoea. VFEND dosage: 200 MG (200 MG, 1 IN 1 D). During the same period patient was treated with MICOFUNGIN, AMIODARONE, DILANTIN. Patient recovered.
Vfend Side Effects Report #5083078-4
Physician from GERMANY reported VFEND problem on Aug 04, 2006. Female patient was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: enterocolitis haemorrhagic, gastrointestinal haemorrhage, liver function test abnormal. VFEND dosage: 200 MG (100 MG) ORAL. During the same period patient was treated with CEFTAZIDIME PENTAHYDRATE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5086128-4
VFEND problem was reported by a Physician from FRANCE on Aug 11, 2006. Male patient, 53 years of age, weighting 88.18 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: cholestasis, thrombocytopenia. VFEND dosage: 400 MG (2 IN 1 D0, INTRAVENOUS. During the same period patient was treated with BACTRIM, TRAMADOL, ZOLPIDEM TARTRATE, OMEPRAZOLE, LOVENOX, AUGMENTIN, XANAX. Patient recovered.
Vfend Side Effects Report #5086141-7
Physician from JAPAN reported VFEND problem on July 11, 2006. Male patient, 71 years of age, weighting 132.3 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, renal impairment. VFEND dosage: 400 MG, ORAL. During the same period patient was treated with ZYVOX. Patient recovered.
Vfend Side Effects Report #5086171-5
VFEND problem was reported by a Physician from JAPAN on Aug 09, 2006. Male patient, 51 years of age, was diagnosed with cerebral aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, intravascular haemolysis, shock. VFEND dosage: unknown. During the same period patient was treated with MICAFUNGIN. Patient recovered.
Vfend Side Effects Report #5091904-8
Physician from FRANCE reported VFEND problem on Aug 16, 2006. Female patient, child 4 years of age, weighting 26.46 lb, was diagnosed with asthma, superinfection, infection prophylaxis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: cryoglobulinaemia, ecchymosis, oedema, pain in extremity, toe amputation, vasculitis. VFEND dosage: 100 MG (50 MG, 2 IN 1 D), ORAL. During the same period patient was treated with DOMPERIDONE, SALBUTAMOL, FLUTICASONE PROPIONATE, BACTRIM PEDIATRIC, GRANOCYTE, COTRIMOXAZOL, GAVISCON. Patient recovered.
Vfend Side Effects Report #5092457-0
VFEND problem was reported by a Physician from UNITED STATES on Aug 14, 2006. Female patient, 35 years of age, weighting 135.0 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: vision blurred, vitreous floaters. VFEND dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with DIFLUCAN, HORMONAL CONTRACEPTIVES SYSTEMIC USE. Patient recovered.
Vfend Side Effects Report #5095022-4
Physician from UNITED STATES reported VFEND problem on Aug 18, 2006. Male patient, 67 years of age, weighting 175.0 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: delusion, psychotic disorder. VFEND dosage: 200 MG INTRAVENOUS ; 200 MG ORAL. Patient recovered.
Vfend Side Effects Report #5131076-4
VFEND problem was reported by a Physician from UNITED STATES on May 30, 2006. Female patient, 60 years of age, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, jaundice cholestatic. VFEND dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient recovered.
Vfend Side Effects Report #5131079-X
Physician from UNITED STATES reported VFEND problem on June 27, 2005. Male patient, 65 years of age, was diagnosed with aspergillosis, lung neoplasm malignant and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: folliculitis, rash pruritic. VFEND dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5131080-6
VFEND problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2005. Female patient, 16 years of age, was diagnosed with ill-defined disorder and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, dizziness, hallucination, thinking abnormal, vision blurred, visual disturbance. VFEND dosage: unknown. Patient recovered.
Vfend Side Effects Report #5131081-8
Consumer or non-health professional from UNITED STATES reported VFEND problem on June 24, 2006. Female patient, 62 years of age, weighting 119.0 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: dry skin, photosensitivity reaction, pigmentation disorder, rash, skin exfoliation. VFEND dosage: unknown. During the same period patient was treated with RIFAMPICIN, BIAXIN, ACTONEL. Patient recovered.
Vfend Side Effects Report #5131083-1
VFEND problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 23, 2005. Male patient, weighting 175.0 lb, was diagnosed with candidiasis, urinary tract infection, diabetes mellitus and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. VFEND dosage: 400 MG (200 MG,2 IN 1 D),ORAL. During the same period patient was treated with FLUCONAZOLE, GLYBURIDE, GLUCOPHAGE. Patient recovered.
Vfend Side Effects Report #5131084-3
Health Professional from UNITED STATES reported VFEND problem on Aug 02, 2005. Male patient was diagnosed with meningitis coccidioides and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: fatigue, peripheral motor neuropathy, sensory loss. VFEND dosage: 400 MG (200 MG, BID). During the same period patient was treated with CLOBETASOL, MS CONTIN, FIORICET, PHENERGAN, MORPHINE SULPHATE, KETOROLAC, GUAIFENESIN, LONG TERM MELOXICAM. Patient recovered.
Vfend Side Effects Report #5131086-7
VFEND problem was reported by a Physician from UNITED STATES on Oct 04, 2005. Female patient, 40 years of age, weighting 125.0 lb, was diagnosed with sinusitis fungal and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: altered visual depth perception, amnesia, confusional state, pseudomonas infection. VFEND dosage: 400 MG (200 MG, 2 IN 1 D) , ORAL. Patient recovered.
Vfend Side Effects Report #5131087-9
Physician from UNITED STATES reported VFEND problem on Dec 23, 2005. Male patient, 55 years of age, was diagnosed with bronchopulmonary aspergillosis, graft versus host disease and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, blood creatinine increased, renal failure acute. VFEND dosage: 200 MG (100 MG, 2 IN 1 D) , ORAL. During the same period patient was treated with TACROLIMUS, PREDNISONE, PROTONIX, SOTAOLOL, HYDROXYCHLOROQUINE, BACTRIM DS, VALTREX. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5131088-0
VFEND problem was reported by a Health Professional from UNITED STATES on Nov 07, 2005. Male patient, 56 years of age, was diagnosed with pneumonia fungal and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: deafness. VFEND dosage: 200 MG (100 MG, BID INTERVAL:EVERY DAY ) ORAL. Patient recovered.
Vfend Side Effects Report #5131089-2
Physician from UNITED STATES reported VFEND problem on Jan 30, 2006. Female patient, 58 years of age, weighting 185.0 lb, was diagnosed with bronchopulmonary aspergillosis, hypertension and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, blood pressure increased, confusional state, dizziness, dyspnoea, heart rate decreased, sensory disturbance, therapeutic response unexpected, visual disturbance. VFEND dosage: 400 MG (200 MG , 2 IN 1 D), ORAL. During the same period patient was treated with CLONIDINE, HYDROCHLOROTHIAZIDE, ALBUTEROL, ADVAIR DISKUS, FLONASE, MAGNESIUM, CORAL CALCIUM, CYSTEINE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5131093-4
VFEND problem was reported by a Pharmacist from UNITED STATES on Jan 26, 2006. Female patient was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: neutropenia. VFEND dosage: unknown. During the same period patient was treated with VINCRISTINE. Patient recovered.
Vfend Side Effects Report #5131094-6
Pharmacist from UNITED STATES reported VFEND problem on Feb 28, 2006. Female patient, 45 years of age, was diagnosed with ill-defined disorder and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: abdominal pain, liver function test abnormal. VFEND dosage: unknown. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5131095-8
VFEND problem was reported by a Physician from UNITED STATES on June 01, 2006. Male patient was diagnosed with fungal endocarditis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hallucination, visual disturbance. VFEND dosage: 400 MG (200 MG,2 IN 1 D). During the same period patient was treated with AMIODARONE, COUMADIN, ISORDIL, ZEBETA, POTASSIUM CHLORIDE, LANTUS, ALBUTEROL. Patient recovered.
Vfend Side Effects Report #5131096-X
Consumer or non-health professional from UNITED STATES reported VFEND problem on Mar 23, 2006. Female patient, 43 years of age, weighting 128.0 lb, was diagnosed with aspergillosis, ill-defined disorder and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood alkaline phosphatase increased, body temperature increased, decreased appetite, inflammation. VFEND dosage: 800 MG (400 MG,2 IN 1 D),ORAL. During the same period patient was treated with PAXIL, PROTONIX, AMBIEN, LOPRESSOR, WARFARIN, FENTANYL. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5131097-1
VFEND problem was reported by a Pharmacist from UNITED STATES on Apr 03, 2006. Male patient, 61 years of age, weighting 196.2 lb, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: visual disturbance. VFEND dosage: 400 MG (200 MG, 2 IN 1 D), GASTROENTERAL USE. During the same period patient was treated with ACULAR, AMBIEN, NEURONTIN, ALBUTEROL SOLUTION, CLARINEX, DARVOCET, CORTISPORIN OPTHALMIC. Patient recovered.
Vfend Side Effects Report #5131099-5
Physician from UNITED STATES reported VFEND problem on May 08, 2006. Female patient, 17 years of age, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: encephalopathy, hallucination, mental status changes. VFEND dosage: unknown. During the same period patient was treated with COUMADIN. Patient recovered.
Vfend Side Effects Report #5131104-6
VFEND problem was reported by a Pharmacist from UNITED STATES on Dec 31, 2005. Female patient, 46 years of age, weighting 136.9 lb, was diagnosed with prophylaxis, ill-defined disorder and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood magnesium, blood magnesium decreased, blood potassium decreased, cardiac arrest, electrocardiogram qt prolonged, torsade de pointes. VFEND dosage: unknown. During the same period patient was treated with GATIFLOXACIN, TEQUIN, MAGNESIUM SULPHATE, ACYCLOVIR, MERREM, VANCOMYCIN, POTASSIUM CHLORIDE, CANCIDAS. Patient recovered.
Vfend Side Effects Report #5131109-5
Health Professional from UNITED STATES reported VFEND problem on Jan 06, 2006. Female patient, 45 years of age, weighting 122.0 lb, was diagnosed with aspergilloma and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: hallucination, headache, nausea, photophobia. VFEND dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient recovered.
Vfend Side Effects Report #5097037-9
VFEND problem was reported by a Physician from FRANCE on Aug 22, 2006. Male patient, 68 years of age, weighting 198.4 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, diarrhoea, infarction. VFEND dosage: 200 MG (EVERY DAY), ORAL. During the same period patient was treated with POTASSIUM CHLORIDE, RAMIPRIL, PRAVASTATIN, ERLOTINIB, ACARBOSE, VERAPAMIL, SPIRONOLACTONE, FUROSEMIDE. Patient died on 08/02/2006.
Vfend Side Effects Report #5097573-5
Pharmacist from JAPAN reported VFEND problem on Aug 22, 2006. Female patient, 18 years of age, weighting 97.00 lb, was diagnosed with aspergillosis, immunosuppression and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, hepatic function abnormal, liver disorder, visual disturbance. VFEND dosage: unknown. During the same period patient was treated with CYCLOSPORINE, FLUCONAZOLE, FOSFLUCONAZOLE, SULFAMETHOXAZOLE, BETAMETHASONE. Patient recovered.
Vfend Side Effects Report #5097612-1
VFEND problem was reported by a Physician from UNITED STATES on Aug 22, 2006. Female patient, 16 years of age, weighting 101.4 lb, was diagnosed with sinusitis fungal and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, liver function test abnormal, malabsorption, pneumonia. VFEND dosage: unknown. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5103129-8
Physician from JAPAN reported VFEND problem on Aug 28, 2006. Male patient, 76 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: cardiac failure. VFEND dosage: 600 MG, ORAL. During the same period patient was treated with SEREVENT, CLARITHROMYCIN, BAKTAR. Patient died on 08/27/2006.
Vfend Side Effects Report #5103623-X
VFEND problem was reported by a Physician from UNITED STATES on Aug 26, 2006. Female patient, 61 years of age, weighting 125.0 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: anorexia, chromatopsia, disorientation, photopsia, skin discolouration, weight decreased. VFEND dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ALPHA HYDROXY ACID, SPIRIVA, ADVAIR DISKUS, DYAZIDE, VASOTEC, ZOCOR. Patient recovered.
Vfend Side Effects Report #5104034-3
Physician from JAPAN reported VFEND problem on Aug 30, 2006. Male patient, 72 years of age, weighting 92.59 lb, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, delirium, dizziness, dysphagia, liver disorder, sepsis. VFEND dosage: 300 MG (150 MD, 2 IN 1 D), ORAL. During the same period patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, MUCODYNE, URSO, CLARITHROMYCIN, FLIVAS, AVISHOT, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/30/2006.
Vfend Side Effects Report #5104038-0
VFEND problem was reported by a Physician from JAPAN on Aug 28, 2006. Male patient, 77 years of age, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood pressure decreased, body temperature increased, bronchopulmonary aspergillosis, condition aggravated, dehydration, heart rate decreased, hyperthermia, hypokalaemia. VFEND dosage: 400 MG, ORAL. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.
Vfend Side Effects Report #5104048-3
Physician from FRANCE reported VFEND problem on Aug 30, 2006. Male patient, 68 years of age, weighting 198.4 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardio-respiratory arrest, diarrhoea, infarction. VFEND dosage: 200 MG (EVERY DAY), ORAL. During the same period patient was treated with POTASSIUM CHLORIDE, RAMIPRIL, PRAVASTATIN, ERLOTINIB, ACARBOSE, VERAPAMIL, SPIRONOLACTONE, FUROSEMIDE. Patient died on 08/02/2006.
Vfend Side Effects Report #5104059-8
VFEND problem was reported by a Physician from JAPAN on Aug 30, 2006. Male patient, 71 years of age, weighting 132.3 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, renal impairment. VFEND dosage: 400 MG, ORAL. During the same period patient was treated with ZYVOX, ASPIRIN, DIOVAN, FAMOTIDINE, LASIX, LIVALO, CONIEL, MUCODYNE. Patient recovered.
Vfend Side Effects Report #5104074-4
Physician from JAPAN reported VFEND problem on Aug 30, 2006. Male patient, 78 years of age, weighting 119.0 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, diffuse alveolar damage, interstitial lung disease, metabolic disorder, pulmonary oedema, renal failure, respiratory failure, scar. VFEND dosage: unknown. During the same period patient was treated with MEROPEN, FIRSTCIN, ERYTHROCIN, BIAPENEM, VANCOMYCIN. Patient died on 02/11/2006.
Vfend Side Effects Report #5106223-0
VFEND problem was reported by a Physician from JAPAN on Aug 30, 2006. Female patient was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: delusion, hallucination, hallucination, auditory, mania. VFEND dosage: 600 MG, ORAL. Patient recovered.
Vfend Side Effects Report #5108692-9
Physician from FRANCE reported VFEND problem on Sept 04, 2006. Male patient, 38 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. VFEND dosage: 800 MG (400 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with FLAGYL I, TRAMADOL, AMIKIN, CYMEVAN, TIENAM. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5109490-2
VFEND problem was reported by a Physician from JAPAN on Sept 06, 2006. Male patient, 77 years of age, was diagnosed with pulmonary mycosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: asthenia, blood alkaline phosphatase increased, condition aggravated, decreased appetite, optic neuritis, pulmonary mycosis, white blood cell count decreased. VFEND dosage: 300 MG (150 MG, 2 IN 1 D), ORAL. During the same period patient was treated with GASTER D, LEVOFLOXACIN, CLARITHROMYCIN, PERDIPIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5110904-2
Physician from JAPAN reported VFEND problem on Sept 06, 2006. Male patient was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. VFEND dosage: 400 MG, INTRAVENOUS. Patient died on 09/05/2006.
Vfend Side Effects Report #5110906-6
VFEND problem was reported by a Physician from JAPAN on Sept 06, 2006. Male patient, 71 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. VFEND dosage: unknown. Patient died on 08/26/2006.
Vfend Side Effects Report #5113789-3
Physician from JAPAN reported VFEND problem on Sept 07, 2006. Male patient, 20 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: photophobia, retinal haemorrhage. VFEND dosage: 400 MG, NTRAVENOUS. Patient recovered.
Vfend Side Effects Report #5115395-3
VFEND problem was reported by a Physician from FRANCE on Sept 11, 2006. Male patient was diagnosed with aspergillosis, sarcoidosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: respiratory failure. VFEND dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. Patient recovered.
Vfend Side Effects Report #5115740-9
Pharmacist from UNITED STATES reported VFEND problem on Sept 26, 2006. Male patient, 61 years of age, weighting 238.1 lb, was diagnosed with fungal infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, photopsia, visual disturbance. VFEND dosage: 600 MG DAILY IV. Patient recovered.
Vfend Side Effects Report #5115741-0
VFEND problem was reported by a Pharmacist from UNITED STATES on Sept 26, 2006. Female patient, 86 years of age, weighting 85.98 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: hallucination. VFEND dosage: 170 MG Q 12 H. Patient recovered.
Vfend Side Effects Report #5118563-X
Physician from JAPAN reported VFEND problem on Sept 15, 2006. Male patient, 77 years of age, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood pressure decreased, bronchopulmonary aspergillosis, condition aggravated, dehydration, hyperthermia, hypokalaemia, oral intake reduced. VFEND dosage: 400 MG, ORAL. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.
Vfend Side Effects Report #5120760-4
VFEND problem was reported by a Pharmacist from UNITED STATES on Oct 03, 2006. Female patient, 18 years of age, weighting 94.58 lb, was diagnosed with bronchopulmonary aspergillosis allergic and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: visual disturbance. VFEND dosage: 200 MG PO Q 12 HR. Patient recovered.
Vfend Side Effects Report #5126328-8
Physician from UNITED STATES reported VFEND problem on Sept 25, 2006. Female patient, 35 years of age, weighting 135.0 lb, was diagnosed with aspergillosis, ear infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: aspergillosis, ear infection, vision blurred, visual disturbance, vitreous floaters. VFEND dosage: 400 MG (200 MG, 2 IN 1 D) ORAL. During the same period patient was treated with DIFLUCAN, HORMONAL CONTRACEPTIVES NOS SYSTEMIC USE. Patient recovered.
Vfend Side Effects Report #5127459-9
VFEND problem was reported by a Health Professional from FRANCE on Sept 26, 2006. Male patient, 68 years of age, weighting 198.4 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: arrhythmia, diarrhoea. VFEND dosage: 200 MG, (EVERY DAY), ORAL. During the same period patient was treated with ERLOTINIB, ACARBOSE, POTASSIUM CHLORIDE, RAMIPRIL, PRAVASTATIN, VERAPAMIL HYDROCHLORIDE, SPIRONOLACTONE, FUROSEMIDE. Patient died on 08/02/2006.
Vfend Side Effects Report #5127562-3
Physician from JAPAN reported VFEND problem on Sept 25, 2006. Male patient, 71 years of age, weighting 111.1 lb, was diagnosed with bacterial infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bacterial infection, condition aggravated, dyspnoea, interstitial lung disease, lung infiltration, metastases to bone, metastases to lung, multiple myeloma, oxygen saturation decreased. VFEND dosage: 140 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with PURSENNID, OMEPRAZOLE, TAMSULOSIN, LOXONIN, APLACE, MAGNESIUM OXIDE, TETRAMIDE. Patient was hospitalized. Patient died on 08/25/2006.
Vfend Side Effects Report #5128224-9
VFEND problem was reported by a Physician from NETHERLANDS on Sept 28, 2006. Female patient, 36 years of age, was diagnosed with candidiasis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, therapeutic agent toxicity. VFEND dosage: 800 MG. During the same period patient was treated with CYCLOSPORINE, AMPHOTERICIN B. Patient recovered.
Vfend Side Effects Report #5128254-7
Physician from UNITED KINGDOM reported VFEND problem on Sept 28, 2006. Male patient, 15 years of age, weighting 114.9 lb, was diagnosed with meningitis cryptococcal and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blister, lip blister, rash erythematous, skin hyperpigmentation. VFEND dosage: 800 MG (400 MG, 2 IN 1 D), ORAL. During the same period patient was treated with MERCAPTOPURINE, OMEPRAZOLE, SEPTRAN. Patient recovered.
Vfend Side Effects Report #5128302-4
VFEND problem was reported by a Physician from JAPAN on Sept 28, 2006. Female patient, 71 years of age, weighting 108.9 lb, was diagnosed with bronchopulmonary aspergillosis, lung neoplasm malignant and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, hepatic function abnormal, malaise, nausea, oral intake reduced. VFEND dosage: 400 MG (2 IN 1 D), ORAL; 300 MG, INTRAVENOUS. During the same period patient was treated with TAXOTERE, PARAPLATIN, ITRACONAZOLE. Patient recovered.
Vfend Side Effects Report #5131078-8
Pharmacist from UNITED STATES reported VFEND problem on June 12, 2006. Male patient, weighting 154.3 lb, was diagnosed with antifungal prophylaxis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction. VFEND dosage: 400MG (200MG, BID INTERVAL: EVERY DAY), ORAL. During the same period patient was treated with PROGRAF, IMURAN, PREDNISONE, MUCINEX, PERCOCET, BACTRIM, VALCYTE. Patient recovered.
Vfend Side Effects Report #5132427-7
VFEND problem was reported by a Physician from JAPAN on Oct 04, 2006. Male patient, 71 years of age, weighting 111.1 lb, was diagnosed with aspergillosis, bacterial infection and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, condition aggravated, interstitial lung disease, multiple myeloma, pneumocystis jiroveci pneumonia. VFEND dosage: 140 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with MAXIPIME, PURSENNID, OMEPRAZOLE, TAMSULOSIN, LOXONIN, APLACE, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/26/2006.
Vfend Side Effects Report #5133244-4
Physician from JAPAN reported VFEND problem on Oct 05, 2006. Male patient, 75 years of age, weighting 104.7 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: aspergillosis, blood glucose increased, cardiac failure acute, cardio-respiratory arrest, pyrexia. VFEND dosage: 600 MG (2 IN 1 D), ORAL. During the same period patient was treated with NOVORAPID, HUMULIN N, SEREVENT, CLARITHROMYCIN, SULFAMETHOXAZOLE, MICAFUNGIN, MARZULENE S. Patient was hospitalized. Patient died on 08/26/2006.
Vfend Side Effects Report #5140675-5
VFEND problem was reported by a Physician from JAPAN on Oct 12, 2006. Female patient, 49 years of age, weighting 81.57 lb, was diagnosed with pneumonia and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: haemorrhage, macular oedema, visual acuity reduced. VFEND dosage: 400 MG, ORAL. During the same period patient was treated with MYCOSYST, SULFAMETHOXAZOLE, PURSENNID, MAGNESIUM OXIDE, MUCOSOLVAN, MUCODYNE, BROCIN, DEXTROMETHORPHAN HYDROBROMIDE. Patient recovered.
Vfend Side Effects Report #5140852-3
Pharmacist from UNITED STATES reported VFEND problem on Oct 12, 2006. Male patient, 29 years of age, weighting 80.00 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood urea increased, dehydration. VFEND dosage: (50 MG, INTRAVENOUS. During the same period patient was treated with ERAXIS, TOTAL PARENTERAL NUTRITION, REMODULIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5140868-7
VFEND problem was reported by a Physician from JORDAN on Oct 13, 2006. Female patient, 32 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: road traffic accident. VFEND dosage: 400 MG (200 MG, 2 IN 1 D) ORAL. During the same period patient was treated with LAMIVUDINE, IMIPENEM, VANCOMYCIN. Patient died on 04/01/2006.
Vfend Side Effects Report #5141002-X
Health Professional from FRANCE reported VFEND problem on Oct 13, 2006. Male patient, 72 years of age, was diagnosed with bronchopulmonary aspergillosis, prophylaxis against gastrointestinal ulcer, agranulocytosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, blood disorder, coordination abnormal, fatigue, hyporeflexia, polyneuropathy. VFEND dosage: 600 MG (300 MG, FREQUENCY: BID), ORAL. During the same period patient was treated with OMEPRAZOLE, VALACYCLOVIR, PREDNISONE, BISOPROLOL FUMARATE, VALSARTAN, ACETYLSALICYLATE LYSINE, PENTAMIDINE ISETHIONATE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5143385-3
VFEND problem was reported by a Physician from JAPAN on Oct 17, 2006. Female patient, 50 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: delusion, hallucination, hallucination, auditory, mania. VFEND dosage: 600 MG, ORAL. Patient recovered.
Vfend Side Effects Report #5144518-5
Pharmacist from JAPAN reported VFEND problem on Oct 18, 2006. Male patient, 78 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: abasia, hypoaesthesia, pain in extremity. VFEND dosage: 1200 MG (600 MG, 2 IN 1 D), ORAL ; 600 MG (300 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, TAMSULOSIN, BESACOLIN, METHYCOBAL, PLETAL, AMOBAN. Patient recovered.
Vfend Side Effects Report #5144581-1
VFEND problem was reported by a Physician from JAPAN on Oct 18, 2006. Male patient, 57 years of age, weighting 112.4 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood pressure immeasurable, bronchopulmonary aspergillosis, cardiac arrest, condition aggravated, eye rolling, feeling abnormal, heart rate decreased. VFEND dosage: 400 MG (200 MG, FREQUENCY: BID), INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, FIRSTCIN, CARBENIN, SAXIZON, OMEPRAL, MUCOSTA, LASIX, FUNGIZONE. Patient was hospitalized. Patient died on 09/05/2006.
Vfend Side Effects Report #5202905-0
Pharmacist from UNITED STATES reported VFEND problem on Aug 01, 2006. Female patient was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: confusional state, overdose. VFEND dosage: 2400 MG, ORAL. Patient recovered.
Vfend Side Effects Report #5146288-3
VFEND problem was reported by a Physician from JAPAN on Oct 19, 2006. Male patient, 87 years of age, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: aspergillosis, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, interstitial lung disease. VFEND dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, IMMUNOSUPPRESSIVE AGENTS. Patient died on 10/01/2006.
Vfend Side Effects Report #5146332-3
Physician from UNITED KINGDOM reported VFEND problem on Oct 19, 2006. Female patient, child 12 years of age, weighting 74.96 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: erythema, rash, skin depigmentation. VFEND dosage: 480 MG (240 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ONCASPAR, DANAPAROID, OMEPRAZOLE, METHOTREXATE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5146451-1
VFEND problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2006. Female patient, 69 years of age, weighting 114.0 lb, was diagnosed with aspergillosis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, gastric ulcer haemorrhage, hepatic failure, ill-defined disorder, international normalised ratio increased, renal failure, white blood cell count increased. VFEND dosage: 80 MG (40 MG, 2 IN 1 D), ORAL. During the same period patient was treated with XOPENEX, SPIRIVA, ADVAIR DISKUS, COLACE, METOPROLOL TARTRATE, MAGNESIUM OXIDE, LEVAQUIN, ROCEPHIN. Patient recovered.
Vfend Side Effects Report #5146613-3
Physician from JAPAN reported VFEND problem on Oct 20, 2006. Male patient, 71 years of age, weighting 132.3 lb, was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, blood pressure decreased, renal impairment. VFEND dosage: 400 MG, ORAL. During the same period patient was treated with ZYVOX, ASPIRIN, DIOVAN, FAMOTIDINE, LASIX, LIVALO, CONIEL, MUCODYNE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5149954-9
VFEND problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 60 years of age, weighting 184.0 lb, was diagnosed with cystitis and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose decreased, international normalised ratio increased, oedema peripheral, pain, thrombosis. VFEND dosage: unknown. Patient recovered.
Showing 1-100 of 280 Next >
Ask Our Patient Community about Vfend |
||
|
|
||
|
|
||